Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001661539-22-000005

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 146,621 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Trevejo Jose M. · CHIEF MEDICAL OFFICER

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-02-01 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +116,424 $20.64 2032-01-31 116,424 116,424 D
2022-02-01 Grant or award : show line 2 in the form Restricted Stock Units +30,197 30,197 30,197 D
Loading xslF345X03/wf-form4_164392778280060.xml…